1Kircik LH. Re -evaluating treatment targets in acne vulgaris:adapting to a new understanding of pathophysiology [J]. J DrugsDermatol, 2014, 13(6): s57-s60.
2Norris JF, Cunliffe WJ. A histological and immunocytochemicalstudy of early acne lesions [J]. Br J Dermatol, 1988, 118(5):651-659.
3Jeremy AH, Holland DB, Roberts SG, et al. Inflammatory eventsare involved in acne lesion initiation[J]. J Invest Dermatol, 2003,121(1): 20-27.
4Del RJ, Kircik LH. The sequence of inflammation, relevantbiomarkers, and the pathogenesis of acne vulgaris: what does re-c-ent research show and what does it mean to the dink_ian.[J|. JDrugs Dermatol. 2013, 12(8 Suppl) : sl()9-sl 15.
5Kang S, Cho S, Chung JH. et al. Inflammation and extracellularmatrix degradation mediate(丨 by activated transcription factors nu-clear factor-kappaB and activator protein-1 in inflammatory acnelesions in vivo[J]. Am J Pathol. 2005, 166(6) ; 1691-1699.
6Trivetli NR, Gilliland KL, Zhao W, et al. Gene array expressionprofiling in acne lesions reveals marked upregulation of genesinvolved in inflammation and matrix remodeling!J |. J Invest Der-matol. 2006, 126(5): 1071-1079.
7Burkhart CG, liurkharl CN. Expanding the mitTocomeclone theoryand acne theraf)eutics: Prof)ionihacterium acnes biofilm producesl)io)ogical glue that holds (‘orneocytes together to form plug|Jj. JAm Acad Dermatol, 2007, 57(4): 722-724.
8Ciraham GM, Karrar Ml). Cruse-Sawyer JK, et al. Proinflammato-ry cytokine production f)y human keratinocytes stimulated wilhPropionibacterium acnes and P. twrnis GroKL[J |. Br J Dermalol,2004, 150f3): 421-428.
9Vowels BR, Yang S, Leyden JJ. Induction of proinflammatorycytokines by a soluble factor of Propionibacterium acnes: impli-cations for chronic inflammatory acne[J]. Infect 丨nimun,丨 995, 63(8); 3158-3165.
10Jugeau S, Tenaud 1, Knol AC, et al. Induction of toll-like re-ceptors by Propionihacterium ac:nes|J ]. Br J Dermatol, 2005, 153(6): 1105-1113.
